Behavior and neuropsychiatric manifestations in Angelman syndrome.
about
The molecular basis of cognitive deficits in pervasive developmental disordersShort alleles, bigger smiles? The effect of 5-HTTLPR on positive emotional expressions.Reward processing in autism: a thematic series.Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse modelsDrosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism.An open-label pilot trial of minocycline in children as a treatment for Angelman syndromeIRBIT regulates CaMKIIα activity and contributes to catecholamine homeostasis through tyrosine hydroxylase phosphorylation.Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPANeurodevelopmental profile in Angelman syndrome: more than low intelligence quotient.Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model.Angelman syndrome: review of clinical and molecular aspects.Unmet clinical needs and burden in Angelman syndrome: a review of the literature.Hypersociability in the Angelman syndrome mouse model.Melatonin and Angelman Syndrome: Implications and Mathematical Model of Diurnal Secretion.Effect of epilepsy on autism symptoms in Angelman syndrome.Enhanced Nociception in Angelman Syndrome Model Mice.Two Sisters with Angelman Syndrome: A Case Series Report.Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant gene associated with Angelman syndromeA behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel mutants
P2860
Q26991872-3CD9FD9A-4B6A-4CF3-8996-033EAAE27BA2Q30377588-40A25F35-96DA-4039-AB45-0C75E30F841AQ30462673-10F3E70F-8259-44D5-8FCB-205BF435196BQ34391238-5FB70463-E60A-4F0D-8556-DEFE5E81664FQ34580149-615DF01B-01C4-4399-B664-25C9A67CBD0FQ34769566-DF68D4DB-36BD-40CF-97D0-76206839B505Q35566881-D51EA7BA-C127-472E-AD0E-E94E90E7515DQ35952108-6D8AAD3D-B319-4C2C-AB9B-90B0D9DBB28FQ37355771-97A19322-75F5-441A-B82C-982DB2F6C2F1Q37491493-C2A430FB-112B-4268-885E-4F75F0CA4334Q38216017-22596E63-6336-4115-B0E6-AF3DDD0FF528Q42689806-55AB1613-2572-4C95-A621-7BC36DB88ECFQ47349205-BE5262FD-CB26-43A4-862F-24B7FD2A4705Q47555093-5ED36126-02B4-450A-9F31-A95C179FEA2AQ47558616-3D5A0F0E-964A-47F2-A70B-2CA9AACB86D7Q47633059-00A1D7B8-03A1-4258-8E2D-256F0FDC690DQ55203464-57C311E9-9F4D-4E77-BE5F-B103A2CB7EEEQ57168803-87018D71-0D18-499C-98C9-87E4979B6603Q58741545-DE9C1E26-F21B-4F61-8BBF-5C1745CC3142
P2860
Behavior and neuropsychiatric manifestations in Angelman syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Behavior and neuropsychiatric manifestations in Angelman syndrome.
@en
Behavior and neuropsychiatric manifestations in Angelman syndrome.
@nl
type
label
Behavior and neuropsychiatric manifestations in Angelman syndrome.
@en
Behavior and neuropsychiatric manifestations in Angelman syndrome.
@nl
prefLabel
Behavior and neuropsychiatric manifestations in Angelman syndrome.
@en
Behavior and neuropsychiatric manifestations in Angelman syndrome.
@nl
P2860
P356
P1476
Behavior and neuropsychiatric manifestations in Angelman syndrome
@en
P2093
Guy Cheron
Karine Pelc
P2860
P304
P356
10.2147/NDT.S2749
P407
P50
P577
2008-06-01T00:00:00Z